Cell phone radiation exposure may lead to increased rates of rare cancers

According to new report from Microwave News, the U.S. National Toxicology Program (NTP) has found increased rates of rare cancers of the heart and brain in animals exposed to cell phone radiation in a long-awaited multi-million dollar two-year study.

Christopher Portier, former Director of the National Toxicology Program noted, "This is the best designed animal study ever conducted on this topic."

Ron Melnick, who led the original NTP study design team, confirmed information leaked by unnamed sources at the National Institute of Health familiar with the study, "The experiment has been done and, after extensive reviews, the consensus is that the same tumors increased in animals that have also been found in some human studies."

"This is extremely powerful evidence," stated Robert Morris MD PhD, Environmental Health Trust (EHT) Senior Medical Advisor. "For more than two decades, many have dismissed cancer risks from cell phones because conventional understanding of the effect of microwaves would suggest there is no mechanism for this to occur. That argument is officially dead."

Evidence has mounted since 2011, when the World Health Organization's International Agency for Research on Cancer deemed radiation from cell phones and other wireless transmitting devices a "possible human carcinogen." Added EHT President Devra Davis PhD MPH, "Every compound known to cause cancer in humans also produces it in animals when well studied. We have to stop experimenting on ourselves and our children and start a vigorous discussion of what we can do right now to prevent a potential public health disaster while we still have time to do so."

Melnick also told Microwave News, "These data redefine the cell phone radiation controversy. This is a major public health concern."


Environmental Health Trust


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
New type of blood test can be used to detect cancers as well as metastatic disease